Consensus Guidance May Improve Sinonasal Mass Outcomes
Multidisciplinary recommendations emphasize biopsy technique, imaging, and pathology review in patients with suspected sinonasal malignancy.
By
Andrea Surnit
June 2, 2026
Clinical Scorecard: Consensus Guidance May Improve Sinonasal Mass Outcomes
At a Glance
Category Detail
Condition Sinonasal masses
Key Mechanisms Avoiding biopsy and management pitfalls to improve diagnosis and treatment outcomes.
Target Population Patients with unilateral nasal obstruction, epistaxis, cranial neuropathy, facial numbness, or visual disturbances.
Care Setting Multidisciplinary clinical settings involving rhinology, head and neck surgery, and oncology.
Key Highlights
Consensus on avoiding complete excisional biopsy without permanent pathologic diagnosis. Endoscopic endonasal biopsy is preferred for tissue sampling. Imaging recommended prior to biopsy when encephalocele is suspected. Pathology review by sinonasal experts is crucial for accurate diagnosis. Permanent tissue diagnosis required before treatment planning for high-risk procedures.
Guideline-Based Recommendations
Diagnosis
Maintain suspicion for sinonasal malignancy in patients with specific symptoms. Comprehensive nasal endoscopy is essential for evaluation.
Management
Avoid office biopsy of vascular-appearing unilateral nasal masses in adolescent males. Consider imaging of neck, chest, abdomen, and pelvis for metastatic disease in diagnosed malignancies.
Monitoring & Follow-up
Review by pathologists with sinonasal expertise and consider second-opinion reviews.
Risks
Removal of visible tumors before diagnosis may complicate future management.
Patient & Prescribing Data
Patients with sinonasal masses, particularly those with malignancy suspicion.
Minimally invasive approaches are preferred to reduce risks.
Clinical Best Practices
Preserve tumor pedicle during biopsy procedures. Utilize high-resolution MRI for masses with bony destruction.
Related Resources & Content